The
FDA amended the emergency use authorization (EUA) for the Pfizer booster dose to include children ages 12 to 15. The interval between the first vaccine set and the Pfizer booster dose will be shortened to 5 months. The amended EUA will also allow booster doses for some immunocompromised children ages 5 to 11.